MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $10,754,000 | -46.8% | 3,392,136 | -43.5% | 0.07% | -72.7% |
Q1 2021 | $20,220,000 | +10712.8% | 6,000,000 | +3244.1% | 0.26% | +5020.0% |
Q1 2020 | $187,000 | -68.2% | 179,419 | 0.0% | 0.01% | -58.3% |
Q4 2019 | $588,000 | +10.1% | 179,419 | 0.0% | 0.01% | -14.3% |
Q3 2019 | $534,000 | +18.1% | 179,419 | 0.0% | 0.01% | +40.0% |
Q2 2019 | $452,000 | – | 179,419 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,972,958 | $4,775,000 | 1.26% |
Altium Capital Management LP | 1,250,000 | $3,025,000 | 0.79% |
Rubric Capital Management LP | 11,300,000 | $27,346,000 | 0.76% |
Vivo Capital, LLC | 6,907,189 | $16,715,000 | 0.75% |
DAFNA Capital Management LLC | 1,126,613 | $2,726,000 | 0.72% |
SILVERARC CAPITAL MANAGEMENT, LLC | 365,661 | $885,000 | 0.50% |
Orbimed Advisors | 17,264,764 | $41,781,000 | 0.46% |
Delphi Management Partners VIII, L.L.C. | 256,734 | $621,000 | 0.45% |
Endurant Capital Management LP | 746,514 | $1,807,000 | 0.41% |
Affinity Asset Advisors, LLC | 650,000 | $1,573,000 | 0.40% |